Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3706-3711

  Chung, Daniel C ^a   Brown, Suzanne B ^a,d   Graeme Cook, Fiona ^a   Tillotson, Loyal G ^b   Warshaw, Andrew L ^a   Jensen, Robert T ^c   Arnold, Andrew ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GENOME; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 0032529238     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kloppel, G., In't Veld, P. A., Stamm, B., and Heitz, P. U. Functional endocrine pathology, p. 396. Boston: Blackwell Scientific Publications, 1991.
2. Hruban, R. H., van Mansfeld, A. O. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K. K., Cameron, J. L., and Bos, J. L. K-ras oncogene activation in adenocarcinomas of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol., 143: 545-554, 1993.
3. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L. T., Yeo, C. J., and Kern, S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025-3033, 1994.
4. Caldas, C., Hahn, S., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
5. Hahn, S., Schutte, M., Hoque, A., Moskaluk, C., da Costa, L., Rozenblum, E., Weinstein, C., Fischer, A., Yeo, C., Hruban, R., and Kern, S. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
6. Yashiro, T., Fulton, N., Hara, H., Yasuda, K., Montag, A., Yashiro, N., Straus, F., Ito, K., Aiyoshi, Y., and Kaplan, E. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery (St. Louis), 114: 758-764, 1993.
7. Evers, B. M., Rady, P. L., Sandoval, K., Arany, I., Tyring, S. K., Sanchez, R. L., Nealon, W. H., Townsend, C. M., and Thompson, J. C. Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene. Ann. Surg., 219: 596-604, 1994.
8. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S., and Itakura, M. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res., 52: 5061-5064, 1992.
9. Eubanks, P. J., Sawicki, M. P., Samara, G. J., Gatti, R., Nakamura, Y., Tsao, D., Johnson, C., Hurwitz, M., Wan, Y-J., and Passaro, E. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am. J. Surg., 167: 180-185, 1994.
10. Hessman, O., Lindberg, D., Skogseid, B., Carling, T., Hellman, P., Rastad, J., Akerstrom, G., and Westin, G. Mutation of the multiple endocrine neoplasia type I gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res., 58: 377-379, 1998.
11. Toliat, M-R., Berger, W., Ropers, H.H., Neuhaus, P., and Wiedenmann, B. Mutations in the MEN1 gene in sporadic neuroendocrine tumours of gastroenteropancreatic system. Lancet, 350: 1223, 1997.
12. Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W-S., Agarwal, S. K., Debelenko, L. V., Kester, M. B., Guru, S. C., Manickam, P., Olufemi, S-E., Yu, F., Heppner, C., Crabtree, J. S., Skarulis, M. C., Venzon, D. J., Emmert-Buck, M. R., Spiegel, A. M., Chandrasekharappa, S. C., Collins, F. S., Burns, A. L., Marx, S. J., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res., 57: 4682-4686, 1997.
13. Chung, D. C., Smith, A. P., Louis, D. N., Graeme-Cook, F., Warshaw, A. L., and Arnold, A. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J. Clin. Invest., 100: 404-410, 1997.
14. Parangi, S., Dietrich, W., Christofori, G., Lander, E. S., and Hanahan, D. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res., 55: 6071-6076, 1995.
15. Dietrich, W., Radany, E., Smith, J., Bishop, J., Hanahan, D., and Lander, E. Genomewide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Proc. Natl. Acad. Sci. USA, 91: 9451-9455, 1994.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. Current Protocols in Molecular Biology, pp. 9.16-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Tahara, H., Smith, A. P., Gaz, R. D., Cryns, V. L., and Arnold. A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res., 56: 599-605, 1996.
18. Arnold, A., Staunton, C. E., Kim, H. G., Gaz, R. D., and Kronenberg, H. M. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N. Engl. J. Med., 318: 658-662, 1988.
19. Cryns, V. L., Yi, S. M., Tahara, H., Gaz, R. D., and Arnold, A. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer, 13: 9-17, 1995.
20. Kruzelock, R. P., Murphy, E. C., Strong, L. C., Naylor, S. L., and Hansen, M. F. Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res., 57: 106-109, 1997.
21. Bell, G., Karam, J., and Rutter, W. Polymorphic DNA region adjacent to the 5′-end of the human insulin gene. Proc. Natl. Acad. Sci. USA, 78: 5759-5763, 1981.
22. European Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75: 1305-1315, 1993.
23. Hahn, S. A., Seymour, A. B., Hoque, A. T. M. S., Schutte, M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res., 55: 4670-4675, 1995.
24. Davoren, P. M., and Epstein, M. T. Insulinoma complicating tuberous sclerosis. J. Neurol. Neurosurg. Psychiatry, 55: 1209, 1992.
25. Schwarzkopf, G., and Pfisterer, J. Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence? Zenthl. Pathol., 139: 477-481, 1994.
26. Iwamura, Y., Futagawa, T., Kaneko, M., Nakagawa, K., Kawai, K., Yamashita, K., Nakamura, T., and Hayashi, H. Co-deletions of the retinoblastoma gene and Wilms' tumor gene and rearrangement of the Krev-1 gene in a human insulinoma. Jpn. J. Clin. Oncol., 22: 6-9, 1992.
27. Aszodi, A., Leeming, R. A., Lash, R. H., Olsen, M. M., and Ponsky, J. L. Giant nonfunctioning islet cell tumor requiring pancreaticoduodenectomy and complete liver revascularization. J. Surg. Oncol., 53: 273-276, 1993.
28. Tung, W. S., Shevlin, D. W., Kaleem, Z., Tribune, D. J., Wells, S. A., and Goodfellow, P. J. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. Genes Chromosomes Cancer, 19: 43-51, 1997.
29. Muscarella, P., Melvin, W. S., Fisher, W. E., Poor, J., Ellison, E. C., Herman, J. G., Schirmer, W. J., Hitchcock, C. L., DeYoung, B. R., and Weghorst, C. M. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res., 58: 237-240, 1998.
30. Walker, G. J., Palmer, J. M., Walters, M. K., Nancarrow, D. J., Parsons, P. G., and Hayward, N. K. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions. Oncogene, 9: 819-824, 1994.
31. Li, Y-J., Hoang-Xuan, K., Delattre, J-Y., Poisson, M., Thomas, G., and Hamelin, R. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) in gliomas. Oncogene, 11: 597-600, 1995.
32. Schmidt, E. E., Ichimura, K., Reifenberger, G., and Collins, V. P. CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994.
33. Hanahan, D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature (Lond.), 315: 115-122, 1985.
34. Shi, Y. P., Naik, P., Dietrich, W. F., Gray, J. W., Hanahan, D., and Pinkel, D. DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice. Genes Chromosomes Cancer, 19: 104-111, 1997.
35. Claudio, J., Malo, D., and Rouleau, G. The mouse neurofibromatosis type 2 gene maps to chromosome 11. Genomics, 21: 437-439, 1994.